MedTrace Logo

Psychoeducational Intervention to Promote Adolescents' Mental Health Literacy in a School Context

NCT03872817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-03-13

No results posted yet for this study

Summary

Mental Health Literacy was defined as knowledge and beliefs about mental disorders that aid in its recognition, management or prevention. Portugal is the European country with the highest prevalence of mental illness in the population (22.9%) and anxiety disorders are the most common (16.5%). Approximately 20% of children and adolescents suffer from some mental disorder and about 8% of adolescents aged 13 to 18 years have some anxiety disorders. Portugal School Health Program 2015 evidences the promotion of health literacy and anxiety as areas of intervention in adolescence. The investigators intend to know the feasibility of a psychoeducational intervention to promote adolescents' mental health literacy (MHL) about anxiety in a school context.

Conditions

  • Health Literacy

Interventions

OTHER

Intervention ProLiSMentAl

Using different methods and pedagogical techniques, mental health literacy psychoeducational intervention called "ProLiSMentAl" consist of 4 sessions of 90 minutes: 1) improvement social anxiety recognition; 2) prevention strategies; 3) self-help strategies; 4) knowledge of first aid strategies and 5) knowledge of professionals and treatments available.

Sponsors & Collaborators

  • Escola Superior de Enfermagem de Coimbra

    lead OTHER

Principal Investigators

  • Tânia Morgado, RN, MSc · CHUC, EPE, EsenfC and UICISA:E

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-02
Primary Completion
2016-03-13
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03872817 on ClinicalTrials.gov